Protocolo diagnóstico y tratamiento de la enfermedad linfática aguda

  1. García, A. Galindo
  2. Ducajú, G. Moñux
  3. Conejero, A. Martín
  4. Hernando, F.J. Serrano
Revue:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Année de publication: 2017

Titre de la publication: Enfermedades cardiológicas (VII) Enfermedades vasculares

Serie: 12

Número: 41

Pages: 2458-2461

Type: Article

DOI: 10.1016/J.MED.2017.09.014 DIALNET GOOGLE SCHOLAR

D'autres publications dans: Medicine: Programa de Formación Médica Continuada Acreditado

Résumé

Abstract Lymphangitis is an inflammatory process of the lymphatic canals, which commonly develops after the inoculation of microorganisms in the lymphatic vessels through a skin defect or as a complication of a more distal infection. Acute lymphangitis presents as an extensive skin disorder, which is accompanied by erythematous plaques and heat and can be accompanied by systemic manifestations such as fever. The microorganisms most often involved are beta-haemolytic streptococci and methicillin-sensitive Staphylococcus aureus (MSSA), although in certain circumstances the infection is caused by methicillin-resistant Staphylococcus aureus (MRSA). The correct diagnosis is based on the medical history and physical examination. We also need to consider the laboratory and microbiological tests for the possible entry point to start appropriate treatment, which will initially be based on empirical antibiotic therapy (typically oral), requiring parenteral therapy, hospitalisation and coverage against MRSA in certain cases.

Références bibliographiques

  • Bruun T, Oppegaard O, Hufthammer KO, Langeland N, Skrede S. Early response in cellulitis: a prospective study of dynamics and predictors. Clin Infect Dis. 2016;63(8):1034-41.
  • Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erisipelas. J Infect. 2012;64(2):148-55.
  • Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ,. Clinical practice guidelines by the Infectious Diseases So-ciety of America for the treatment of methicillin resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.
  • Miller LG, Quan C, Shay A, Mostafaie K, Bharadwa K, Tan N. A prospective investigation of outcomes after hospital discharge for endemic, community acquired methicillin resistant and susceptible Staphylococcus aureus skin infection. Clin Infect Dis. 2007;44:483-92.
  • Pallin DJ, Binder WD, Allen MB, Lederman M, Parmar S, Filbin MR. Clinical trial: comparative effectiveness of cephalexin plus trimethoprimulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis. 2013;56:1754-62.
  • Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL. Practice guidelines for the diagnosis and ma-nagement of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147.